CVS Drug Buyers Face Skeptical 9th Circ. In $121M Retrial Bid
A certified class of insured drug buyers urged the Ninth Circuit on Tuesday to order a new trial after losing claims CVS Pharmacy owes $121 million for overcharging on generic drugs,...To view the full article, register now.
Already a subscriber? Click here to view full article